ServicenavigationHauptnavigationTrailKarteikarten


Forschungsstelle
INNOSUISSE
Projektnummer
9469.1;4 PFLS-LS
Projekttitel
Therapeutic efficiency of drugs administered intradermally by means of a microneedle patch device for the treatment of common diseases such as vitiligo and other troubles of pigmentation, warts, precancerous skin lesions and malignant lesions.
Projekttitel Englisch
Therapeutic efficiency of drugs administered intradermally by means of a microneedle patch device for the treatment of common diseases such as vitiligo and other troubles of pigmentation, warts, precancerous skin lesions and malignant lesions.

Texte zu diesem Projekt

 DeutschFranzösischItalienischEnglisch
Kurzbeschreibung
-
Anzeigen
-
Anzeigen
Abstract
-
Anzeigen
-
Anzeigen

Erfasste Texte


KategorieText
Kurzbeschreibung
(Englisch)
Therapeutic efficiency of drugs administered intradermally by means of a microneedle patch device for the treatment of common diseases such as vitiligo and other troubles of pigmentation, warts, precancerous skin lesions and malignant lesions.
Kurzbeschreibung
(Französisch)
Therapeutic efficiency of drugs administered intradermally by means of a microneedle patch device for the treatment of common diseases such as vitiligo and other troubles of pigmentation, warts, precancerous skin lesions and malignant lesions
Abstract
(Englisch)
This project is aimed at demonstrating the efficacy and efficiency of microneedles currently developed by Debiotech. It intends to demonstrate the ability to precisely control the intradermal delivery of a drug, and to be able to follow up in real time the injection, in order to address the characteristics of this injection such as depth of injection and volume injected.This technology allows the unexplored intradermal route of administration to be investigated and exploited, with cumulative advantages over standards techniques such as pain free delivery, better diffusion in the skin and better control on the delivery.
Abstract
(Französisch)
This project is aimed at demonstrating the efficacy and efficiency of microneedles currently developed by Debiotech. It intends to demonstrate the ability to precisely control the intradermal delivery of a drug, and to be able to follow up in real time the injection, in order to address the characteristics of this injection such as depth of injection and volume injected.This technology allows the unexplored intradermal route of administration to be investigated and exploited, with cumulative advantages over standards techniques such as pain free delivery, better diffusion in the skin and better control on the delivery.